Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST, Joenja, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Surf Air Mobility, Inc. operates as an electric aviation and air travel company. The company was founded by Sudhin Shahani and Liam Fayed in 2021 and is headquartered in Hawthorne, CA.

Vivid Seats, Inc. operates as an online ticket marketplace, which engages in the provision of different selections of events and tickets in North America. It operates through the following segments: Marketplace and Resale. The Marketplace segment acts as an intermediary between event ticket buyers and ticket sellers. The Resale segment acquires tickets to resell on secondary ticket marketplaces, including its own. Its partners include Caesars Entertainment, RollingStone, Marriott Bonvoy, Capital One, American Airlines and others. The company was founded in 2001 and is headquartered in Chicago, IL.

Mobile-health Network Solutions operates as an investment holding company. The company through its subsidiaries provides telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribed and delivered with the medication at their doorsteps. The company's segments include: Telemedicine and Other Services, and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore.

iHeartMedia, Inc. engages in the provision of media and entertainment services. It operates through the following segments: Multiplatform Group, Digital Audio Group, and Audio and Media Services Group. The Multiplatform Group segment consists of Broadcast radio, Networks and Sponsorships and Events businesses. The Digital Audio Group segment focuses on the Digital businesses, including Podcasts. The Audio and Media Services segment includes Katz Media Group ("Katz Media"), the company's full-service media representation business, and RCSSound Software (RCS), a provider of scheduling and broadcast software and services. The company was founded by L. Lowry Mays and B. J. McCombs in May 2007 and is headquartered in San Antonio, TX.

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.

iLearningEngines, Inc. engages in the provision of artificial intelligence automation solutions. It operates at the intersection of three large and growing markets: global artificial intelligence, global e-learning and hyper automation. The company is headquartered in Bethesda, MD.

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.